Recent Progress in MTPConnect's funded projects

Dimerix Limited
DMX-200 (QYTOVRA)
A combination of two drugs that treats COVID-19, influenza and proteinuria, a condition where urine contains high levels of protein caused by CKD.
Follow
Atmo Biosciences
Atmo Gas Capsule
Ingestible capsule that senses and measures various gases along the gastrointestinal (GI) track as a way to identify specific GI disorders.
Follow
Synchron Australia Pty Ltd
Stentrode
A device inserted into a blood vessel near the brain's motor cortex to allow paraplegics to move by thinking.
Follow
Artrya Pty Ltd
Artrya Salix
Using AI to analyse cardiac CT angiography of patients to reduce diagnosis time from up to a week to 10 minutes for those at risk of heart disease.
Follow
Proteomics International Laboratories LTD
PromarkerD
Blood test that uses a unique protein biomarker, or "fingerprint”, to diagnose and predict a person’s risk of developing diabetic kidney disease (DKD)
Follow
OncoRes Medical Pty Ltd
Quantitative Micro-Elastography (QME) Imaging Sys.
Handheld imaging probe that translates the surgeon's sense of touch into a micro-scale image to increase surgical accuracy in removing breast tumors.
Follow
Ferronova Pty Ltd.
Magnetic Probe and Tracer System to detect cancers
Using 'Magnetic Probe' and 'Injectable Magnetic Tracers' instead of radioactive agents to improve imaging and diagnosis of brain and neck cancers.
Follow
Inventia Life Science
Ligō Robot
3D-prints new skin cells and biomaterials that patients need to promote wound healing and re-create a new layer of normal skin.
Follow
Seer Medical
Seer
Aids in the diagnosis and treatment of epilepsy by offering an at home video-EEG service, allowing brain activities to be measured at home.
Follow
Advanced Genetic Diagnostics Pty Ltd
Heart Attack Risk Test
A genetic test that looks for specific variations in a person’s DNA and determines his or her risk for inherited heart disease such as cardiomyopathy.
Follow

All Innovations supported by MTPConnect's accelerator programs

Search

Real-time innovation tracking powered by

HHLogo

Health
Horizon